The company

The company was founded in 2008 based on innovative research from leading scientists in mucosal immunobiology at the University of Gothenburg and the Sahlgrenska University Hospital.

MIVAC Development AB translates university research into pharmaceutical development and commercialization.

The company is centrally located in Gothenburg at the Biotech Center, Arvid Wallgrens backe 20, with access to own laboratory environment.